Key Insights

Highlights

Success Rate

79% trial completion

Published Results

16 trials with published results (23%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

10.1%

7 terminated out of 69 trials

Success Rate

79.4%

-7.1% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

59%

16 of 27 completed with results

Key Signals

16 with results79% success

Data Visualizations

Phase Distribution

55Total
Not Applicable (11)
Early P 1 (1)
P 1 (20)
P 2 (17)
P 3 (4)
P 4 (2)

Trial Status

Completed27
Recruiting14
Not Yet Recruiting7
Terminated7
Active Not Recruiting6
Unknown5

Trial Success Rate

79.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (69)

Showing 20 of 20 trials
NCT05366569Recruiting

Bio-CAR-T BS Study

NCT07191119Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

NCT07529223Not ApplicableNot Yet RecruitingPrimary

Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.

NCT03849651Phase 2Active Not RecruitingPrimary

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

NCT01351545Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT07483476Not Yet RecruitingPrimary

Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia

NCT03590171Phase 2RecruitingPrimary

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT01758042Not ApplicableCompleted

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

NCT02730299Phase 3Completed

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

NCT06705530Phase 1Completed

A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders

NCT06182163Not ApplicableCompletedPrimary

Reduce Sedentary Time in Acute Lymphoblastic Leukemia

NCT03123029Unknown

Expanded Access to Venetoclax

NCT07327138Not ApplicableRecruitingPrimary

Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.

NCT07326930RecruitingPrimary

Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

NCT07297914Phase 2Not Yet RecruitingPrimary

Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

NCT07246213Recruiting

CAYA Cancer Retrospective Cohort Study

NCT03740334Phase 1Active Not RecruitingPrimary

Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL

NCT07227584Phase 2Not Yet Recruiting

ALL Backbone in AYAs

NCT05884333Phase 2Recruiting

Cord Blood Transplant in Adults With Blood Cancers

NCT06882057Phase 2RecruitingPrimary

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

Scroll to load more

Research Network

Activity Timeline